Ask AI
ADA 2026 obesity guide

CE / CME

Emerging Evidence in Obesity Care: An Expert’s Guide to the Evolving Landscape and ADA 2026 Scientific Sessions

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Pharmacists: 0.25 contact hour (0.025 CEUs)

ABIM MOC: maximum of 0.25 Medical Knowledge MOC point

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.25 Nursing contact hour

Released: May 12, 2026

Expiration: May 11, 2027

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A 52-year-old woman with obesity (BMI 36 kg/m²), hypertension, and prediabetes asks about starting treatment and prefers an oral medication. Emerging clinical trial data on oral incretin-based therapies demonstrate meaningful weight loss and improvements in cardiometabolic risk markers, although long-term cardiovascular outcomes data are still limited. 

Which of the following is the most appropriate next step in managing her care?